Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with Type 2 diabetes

Diabetic Medicine

Volumn 23, Issue 9, 2006, Pages 990-995

  Peter, R ^a   Luzio, S D ^a   Dunseath, G ^a   Pauvaday, V ^a   Mustafa, N ^a   Owens, D R ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Fasting plasma glucose; HbA1c; Postprandial glucose; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; CALCULATION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INTERNATIONAL COOPERATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; STANDARDIZATION; WORLD HEALTH ORGANIZATION; AGED; BLOOD; BODY CONSTITUTION; DIET RESTRICTION; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; BLOOD GLUCOSE; BODY CONSTITUTION; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 33747456017     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01941.x     Document Type: Article

References (26)

1. Pickup JC, Williams G. Textbook of Diabetes. Oxford: Blackwell Science 2003.
2. Tahara Y, Shima K. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care 1993; 16: 1313-1314.
3. Goldstein DE, Little RR, Wiedmeyer HM, England JD, McKenzie EM. Glycated hemoglobin: methodologies and clinical applications. Clin Chem 1986; 32-70.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
5. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
6. The DECODE Study Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999; 42: 647-654.
7. Tuomilehto J, Del Prato S. Mealtime glucose regulation in type 2 diabetes. Int J Clin Prac 2001; 55: 380-383.
8. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in Type 2 Diabetes. Diabetes Care 1997; 20: 1822-1826.
9. Haller H. Postprandial glucose and vascular disease. Diabet Med 1997; 14: S50-S56.
10. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
11. Ceriello A. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000; 16: 125-132.
12. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
13. Giugliano D, Paolisso G, Ceriello A. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
14. Ceriello A, Lizzio S, Bortolotti N, Russo A, Motz E, Tonutti L et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998; 21: 1529-1533.
15. Tuomilehto J, Rastenyte D, Qiao Q, Jakovljevic D. Epidemiology of macrovascular disease and hypertension in diabetes mellitus. In DeFronzo RA, Ferrannini E, Keen H, Zimmet P eds. International Textbook of Diabetes Mellitus, 3rd edn. Chichester: John Wiley and Sons Ltd 2004: 1345-1370.
16. Turner RC, Holman RR. Insulin use in NIDDM. Rationale based on pathophysiology of disease. Diabetes Care 1990; 13: 1011-1020.
17. Jeng CY, Hollenbeck CB, Wu MS, Chen YD, Reaven GM. How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes? Diabet Med 1989; 6: 303-8.
18. Bastyr EJ III, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A et al. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group. Diabetes Care 2000; 23: 1236-1241.
19. Bouma M, Dekker JH, de Sonnaville JJ, van der Does FE, de Vries H, Kriegsman DM et al. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care 1999; 22: 904-907.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
21. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Diabetes Care 2003; 26: 1-5.
22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27: S5-S10.
23. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27: S11-14.
24. Ollerton RL, Luzio SD, Owens DR. Modelling the relative contribution of fasting and post-prandial plasma glucose to HbA1c in healthy and type 2 diabetic subjects. Int J Mathemat Educ Sci Technol 2004; 35: 549-552.
25. Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T et al. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1c values. Arch Intern Med 2004; 164: 1627-1632.
26. Monnier L, Caubel C, Colette C, Avignon A, Rabasa-Lhoret R, Boniface H et al. Morning hyperglycemic excursions. A constant failure in the metabolic control of non-insulin using patients with type 2 diabetes. Diabetes Care 2002; 25: 737-741.